Sign up for the QMED & MD+DI Daily newsletter.
Bradley Merrill Thompson
March 1, 2004
1 Min Read
Originally Published MX March/April 2004
GOVERNMENTAL & LEGAL AFFAIRS
Using a benchmarking metric, medtech companies may be able to measure their level of FDA compliance.
Bradley Merrill Thompson
Lately, as companies work to appraise their performance on a variety of levels, status metrics in the form of executive dashboards have received a lot of attention. Companies well aware of the adage "What gets measured gets done" are increasingly looking for quantitative rather than qualitative metrics by which to measure performance in various areas.
About the Author(s)
Bradley Merrill Thompson is a shareholder in the national law firm of Epstein Becker & Green, P.C., based out of the firm’s Washington, DC office. There he counsels software, medical device, and drug companies on a wide range of FDA regulatory issues and leads the firm’s AI practice.
For trade associations, Thompson has served as counsel to AdvaMed and the Continua Health Alliance and as general counsel to the Combination Products Coalition, mHealth Regulatory Coalition, the Clinical Decision Support Coalition, and AI Startups in Health Coalition.
Thompson also serves as Chairman of the Board of EBG Advisors Inc. Affiliated with the law firm, EBG Advisors is a consultancy that takes a multidisciplinary approach to helping healthcare and life sciences companies navigate the obstacles they face.
He served as a member of a workgroup established under the U.S. FDA Safety and Innovation Act to identify key considerations to improve patient safety and promote innovation in health information technology, including mobile medical applications, co-chairing the Regulations Subcommittee.
Thompson has taught food & drug law at Indiana University School of Law-Indianapolis and Columbia Law School. He also has served as Co-Chair of the Food & Drug Law Committee in the American Bar Association and of the Medical Device Committee of FDLI.
He received his B.A. cum laude, and an M.B.A. from the University of Illinois at Urbana-Champaign and his J.D. cum laude from The University of Michigan Law School. Thompson also is presently pursuing a Masters in Applied Data Science at the University of Michigan, which he anticipates completing in 2021.
You May Also Like
Get Your Melons Checked at WalmartMar 4, 2024|3 Min Read
Medtech in a Minute: Integra's Bold Decision, and MoreMar 4, 2024|1 Min Read
Medtronic Won't Back Down but Axonics Stands Its GroundMar 4, 2024|3 Min Read
Empatica Launch Next-Gen FDA-Cleared Epilepsy WatchMar 1, 2024|2 Min Read